copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
OpenEvidence The leading medical information platform
About | OpenEvidence OpenEvidence is the most widely used medical AI among verified U S physicians To date, we have supported over 100 million AI-powered clinical consultations from U S doctors and other frontline clinicians
OpenEvidence AI becomes the first AI in history to score above 90% on . . . OpenEvidence AI, the large language model-based artificial intelligence powering the automatic ingestion, analysis, synthesis, and research on openevidence com, has reached a new milestone as the first AI to score over 90% on the United States Medical Licensing Examination (USMLE)
Announcements - OpenEvidence OpenEvidence AI becomes the first AI in history to score above 90% on the United States Medical Licensing Examination (USMLE) July 14, 2023
OpenEvidence Creates the First AI in History to Score a Perfect 100% on . . . OpenEvidence, a medical search platform that currently provides evidence-based clinical decision and practice support for over 40% of physicians in the United States, was the first to develop an AI system to score over 90% on the USMLE
OpenEvidence 2. 0 Now Available We are dedicated to providing high-quality, evidence-based information at your fingertips In this update, OpenEvidence maintains its emphasis on grounding information in verifiable, trustworthy sources and builds on that foundation to support a wide range of physician needs
OpenEvidence to Become a Mayo Clinic Platform Accelerate Company OpenEvidence, an AI company pursuing foundational work in aligning Large Language Models (LLMs) to the medical domain, announced today it is to become a Mayo Clinic Platform Accelerate company
OpenEvidence and NEJM Group, publisher of the New England Journal of . . . Under this agreement, all published content and multimedia from 1990 forward from NEJM, NEJM Evidence, NEJM AI, NEJM Catalyst, and NEJM Journal Watch will be provided to OpenEvidence to inform answers delivered on the OpenEvidence platform
NCCN and OpenEvidence Collaborate to Bring Clinical Oncology Guidelines . . . This collaboration will enable healthcare professionals, including the hundreds of thousands of U S physicians now using OpenEvidence daily, to access NCCN’s evidence-based, expert consensus-driven recommendations via natural-language search